171 related articles for article (PubMed ID: 12904715)
1. Management of pulmonary hypertension resulting from interstitial lung disease.
Shapiro S
Curr Opin Pulm Med; 2003 Sep; 9(5):426-30. PubMed ID: 12904715
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
[TBL] [Abstract][Full Text] [Related]
3. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
4. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in interstitial lung disease.
Polomis D; Runo JR; Meyer KC
Curr Opin Pulm Med; 2008 Sep; 14(5):462-9. PubMed ID: 18664977
[TBL] [Abstract][Full Text] [Related]
6. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension secondary to interstitial lung disease.
Shlobin OA; Nathan SD
Expert Rev Respir Med; 2011 Apr; 5(2):179-89. PubMed ID: 21510729
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary hypertension].
Kucewicz E; Wojarski J; Goliszek L; Pacholewicz J; Nowak J; Maciejewski T; Puzio J
Anestezjol Intens Ter; 2009; 41(1):51-5. PubMed ID: 19517679
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in interstitial lung disease.
Strange C; Highland KB
Curr Opin Pulm Med; 2005 Sep; 11(5):452-5. PubMed ID: 16093821
[TBL] [Abstract][Full Text] [Related]
10. The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease.
Corte TJ; Gatzoulis MA; Parfitt L; Harries C; Wells AU; Wort SJ
Respirology; 2010 Nov; 15(8):1226-32. PubMed ID: 20920139
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies.
Ghofrani HA; Voswinckel R; Reichenberger F; Weissmann N; Schermuly RT; Seeger W; Grimminger F
Cardiovasc Res; 2006 Oct; 72(1):30-40. PubMed ID: 16934242
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
13. Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease.
Nathan SD
Am J Respir Crit Care Med; 2023 Aug; 208(3):238-246. PubMed ID: 37159942
[TBL] [Abstract][Full Text] [Related]
14. Management of pulmonary arterial hypertension in the neonatal unit.
Krishnan U
Cardiol Rev; 2010; 18(2):73-5. PubMed ID: 20160532
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension.
Tilton RG; Brock TA; Dixon RA
Expert Opin Investig Drugs; 2001 Jul; 10(7):1291-308. PubMed ID: 11772252
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
20. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with acute respiratory distress syndrome.
Kuhlen R; Walbert E; Fränkel P; Thaden S; Behrendt W; Rossaint R
Intensive Care Med; 1999 Jul; 25(7):752-4. PubMed ID: 10470582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
